Cellevate

Cellevate was founded in 2014, is headquartered in Lund, Sweden, lists 11–50 employees, and has $8.5M in recorded funding across 3 rounds.

Headquarters
Lund, Skåne
Employees
11–50
Founded
2014
Business Model
B2B
Total Funding
$8.5M
Last Round
$1.9M Venture RoundMar 2026
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 3 investors for this company. The full record is or through the API.

About

Cellevate AB is a Swedish biotech company headquartered at Medicon Village in Lund that develops Cellevat3d, a nanofiber-based microcarrier technology for 3D cell culture. Originating from a collaborative research project with Lund University's Solid-State Physics department, its microcarriers support cell and gene therapy, vaccine, and viral-vector (AAV and lentivirus) production, aiming to improve the manufacturing of biological drugs.

Summary

Cellevate is a Biotech company based in Lund, Sweden, founded in 2014. It lists 11–50 employees. It has raised $8.5M in total across 3 rounds, most recently a $1.9M Venture Round in Mar 2026. Investors include Industrifonden, European Innovation Council Fund and Almi Invest.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundVenture RoundMar 2026
$1.9M

Sign up to see all 3 events

Funding: Seed through Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series BTotal funding$2.6BMay 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Cellevate on Indexed.vc
<a href="https://indexed.vc/companies/cellevate"><img src="https://indexed.vc/api/badge/company/cellevate" alt="Cellevate on Indexed.vc" width="260" height="76" /></a>